Physician profile
Michael L Egger
NPI 1144370131
$3,015.53
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,199 · 2020: $701 · 2021: $1,115.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $583.94 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $541.06 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $282.43 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $267.11 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $195.97 | 2019-2021 | |
| Lundbeck LLC | $190.14 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $144.15 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $104.25 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $104.11 | 2019-2021 | |
| Eisai INC. | $96.50 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $91.58 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $80.82 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $75.20 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.43 | 2019-2021 | |
| Bausch Health US, LLC | $50.05 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $32.74 | 2019 | |
| Novo Nordisk INC | $27.99 | 2019 | |
| Merck Sharp & Dohme LLC | $26.75 | 2021 | |
| Acadia Pharmaceuticals INC | $18.19 | 2019 | |
| Shire North American Group INC | $14.36 | 2019 | |
| Abbvie INC. | $13.76 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Egger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.